Sale!

Semaglutide Research Peptide | Biovantage Labs

Semaglutide is a GLP-1 receptor agonist analogue studied for its mechanisms in glucose-dependent insulin secretion, glucagon suppression, and gastric motility regulation research models. Biovantage Labs supplies Semaglutide at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry, for laboratory research use. Domestically fulfilled from Canada. Not for human consumption.

Original price was: $40.00.Current price is: $28.00.

Description

Semaglutide Biovantage Labs Research Peptide

Semaglutide is a GLP-1 receptor agonist analogue studied for its mechanisms in glucose-dependent insulin secretion, glucagon suppression, and gastric motility regulation research models. Biovantage Labs supplies Semaglutide at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry, for laboratory research use. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification Detail
Molecular Formula C187H291N45O59
Molecular Weight 4,113.6 Da
Classification GLP-1 receptor agonist analogue
Purity ≥99+% (HPLC/MS verified)
Physical Form Lyophilized white powder
CAS Number 910463-68-2

 

Primary Research Mechanisms

GLP-1 Receptor Agonism and Glucose-Dependent Insulin Secretion

Semaglutide activates the glucagon-like peptide-1 receptor (GLP-1R) on pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner. Research in this area examines the glucose-sensing properties of the GLP-1 pathway and its downstream cAMP signalling cascade.

Comparative incretin receptor research frequently examines Semaglutide alongside Retatrutide. Semaglutide provides a GLP-1-selective baseline while Retatrutide adds GIP and glucagon receptor co-activation, allowing researchers to isolate the specific contributions of each receptor axis to metabolic outcomes.

Glucagon Suppression and Hepatic Glucose Output

Complementary to its insulinotropic effects, Semaglutide is studied for GLP-1R-mediated suppression of glucagon release from pancreatic alpha cells, with downstream effects on hepatic glucose production examined in metabolic research models.

Central Appetite and Satiety Signalling

GLP-1 receptors are expressed in hypothalamic and brainstem nuclei involved in energy homeostasis. Semaglutide research in neurological models examines central mechanisms of satiety signalling, gastric emptying delay, and hypothalamic appetite regulation.

For research examining FGF21 receptor contributions alongside incretin signalling, Trizeptide extends the multi-agonist research framework by adding FGF21R agonism to the GLP-1/GIP axis. A combination not present in Semaglutide or Retatrutide research designs.

Reconstitution Protocol

  • Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
  • Introduce diluent slowly along the interior vial wall. Do not inject directly onto the lyophilized cake
  • Swirl gently until fully dissolved. Do not shake or vortex
  • Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition State Estimated Stability
-20°C to -80°C Lyophilized 24+ months
2°C to 8°C Lyophilized 12 months
Room temperature (20°C) Lyophilized 3 months
2°C to 8°C Reconstituted 7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

Semaglutide Research FAQ

Q: How does Semaglutide differ from Retatrutide in receptor targeting?

A: Semaglutide is a selective GLP-1 receptor agonist. Retatrutide is a tri-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research using both compounds allows for investigation of single-axis versus multi-axis incretin receptor signalling.

Q: Is Semaglutide for human use?

A: No. Semaglutide supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.

 

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related Products

High Quality Research Peptides You Can Trust

Explore premium-grade peptides for scientific research, purity tested, lab certified, and shipped discreetly.